Search Results

American Society for Radiation Oncology Foundation to Award $2.4 Million in Grants to 14 Researchers

The American Society for Radiation Oncology (ASTRO) Foundation will award a total of $2.4 million in research grants to 14 scientists dedicated to advancing patient care in radiation medicine. ASTRO stated that the 2026 awards are the first annual grants issued since the society renamed its foundation to LightSpeed—ASTRO Foundation earlier this year. The rebranded foundation will focus on accelerating relevant research and strengthening workforce development in the field of radiation oncology. This round of funding is co-sponsored by the American Cancer Society, the American Association of Physicists in Medicine, the Breast Cancer Research Foundation, the LUNGevity Foundation, and the Prostate Cancer Foundation. ASTRO CEO Vive...

2026-08-13

U.S. Company Proposes Americium-241 Radioisotope Heating Solution for Spacesuits, Receives Early NASA Research Support

U.S.-based Zeno Power Systems has proposed a radioisotope heating concept for lunar extravehicular activities, planning to use Americium-241 (Am-241) to provide continuous passive warmth for astronauts during lunar nights and in permanently shadowed regions. The proposal has been selected for this year's NASA Innovative Advanced Concepts (NIAC) program, with the potential to receive up to $175,000 in early-stage research funding. The lunar surface environment is one of the key challenges for long-duration crewed missions. Data shows that lunar nights can last approximately two weeks, and extreme low temperatures will limit the duration of astronaut extravehicular activities in shadowed areas and at night. Even with new-generation spacesuits, their cold resistance remains limited...

2026-08-13

Texas to Accelerate Opening of Sterile Fly Facility to Combat New World Screwworm Outbreak

The U.S. Department of Agriculture announced that, in response to the New World screwworm (NWS) outbreak already detected in Texas and New Mexico, the sterile fly facility at Moore Air Base in Edinburg, Texas, will open early next spring, approximately seven months ahead of the original schedule. Construction on the facility began in April of this year, and once completed, it will produce sterile flies to support outbreak control efforts using the Sterile Insect Technique (SIT). Under the plan, the facility will reach full operational capacity by the end of 2028, producing approximately 300 million sterile flies per week. The Sterile Insect Technique works by releasing sterilized flies into the environment to mate with wild screwworms, thereby interrupting the reproductive cycle and reducing the risk of continued parasite spread...

2026-08-12

University of Missouri Receives $1 Million Grant to Research New FLASH Radiotherapy System

On August 11, researchers at the University of Missouri School of Medicine received a $1 million grant from the National Institutes of Health to study a new technology in cancer radiotherapy—the TheryQ FLASHKNiFE system. The project is funded through June 2027. A long-standing challenge in cancer treatment is how to kill tumor cells while protecting surrounding healthy tissue as much as possible. Existing radiotherapy can already achieve millimeter-level precision, but radiation damage and related side effects still limit the dose patients can safely receive. Unlike conventional approaches, FLASH radiotherapy does not primarily alter the direction of radiation beams, but instead delivers irradiation in an extremely short time at an ultra-high dose rate...

2026-08-12

US Oak Ridge National Laboratory Restarts Tungsten-188/Rhenium-188 Generator Production to Support Targeted Cancer Therapy Research

The US Department of Energy's Oak Ridge National Laboratory (ORNL) recently restarted and upgraded its tungsten-188/rhenium-188 (W-188/Re-188) generator manufacturing operations to meet the demand for the rare medical isotope rhenium-188 in targeted cancer therapy research. The laboratory last manufactured such generators in 2011. Radiochemist Becca Hores demonstrated the assembly process of the W-188/Re-188 generator. Depending on radioactivity levels, these generators must be assembled in gloveboxes or hot cells. Image credit: Maggie Gregg/Oak Ridge National Laboratory, US Department of Energy. Rhenium-188 is produced by the radioactive decay of tungsten-188. ORNL irradiates tungsten-186 in the High Flux Isotope Reactor (HFIR) to produce tungsten-188...

2026-08-12

CT "5-Star" Image Quality Scoring May Help Reduce Radiation Dose

A multinational study involving the International Atomic Energy Agency and Massachusetts General Hospital in the United States shows that a standardized 5-star scoring system that considers both radiation dose and CT image quality can produce relatively consistent evaluations across different radiologists and help identify opportunities to reduce patient radiation exposure. This retrospective study included 2,737 adult CT examinations performed at 6 hospitals across 5 European countries, including 1,247 chest CTs and 1,490 abdominal CTs, involving 13 CT scanners. At each hospital, 3 radiologists independently evaluated the examinations using the 5-star framework. Unlike traditional image quality assessments that may favor lower noise...

2026-08-12

Flammable Gas Analysis Completed for Legacy Transuranic Waste Containers at U.S. Savannah River Site

AIKEN, South Carolina — The Solid Waste and Deactivation and Decommissioning team at Savannah River Nuclear Solutions (SRNS) recently completed a critical task, performing flammable gas analysis on multiple legacy high-dose-rate transuranic (TRU) waste containers. The results confirmed that these containers meet safety requirements for shipment to an underground waste disposal facility. Following this analysis, the U.S. Department of Energy Office of Environmental Management will resume shipments of remote-handled transuranic waste drums from the Savannah River Site (SRS) to the Waste Isolation Pilot Plant (WIPP) in New Mexico for permanent disposal. Flammable gas sampling is an important safety step prior to the transportation and disposal of transuranic waste. Workers...

2026-08-11

Brookhaven National Laboratory Pilots Training Program for Nuclear Technology and Radiochemistry Talent

The U.S. Department of Energy's Brookhaven National Laboratory and Suffolk County Community College (SUNY Suffolk) recently completed a pilot program to train talent in nuclear technology and radiochemistry. Eleven students and recent graduates completed one semester of coursework and three weeks of intensive laboratory training, becoming the first cohort to complete the Nuclear Technology and Radiochemistry Technician Pathway (NTRTP) program. SUNY Suffolk student Arin Morton (left) works under the guidance of mentor Michael Chimes at Brookhaven National Laboratory's Isotope Research and Production Division...

2026-08-11

Curium Acquires Belgium's Abscint, Expanding HER2-Targeted Gallium-68 PET Oncology Radiopharmaceutical Diagnostics Pipeline

On August 10, 2026, radiopharmaceutical company Curium announced the completion of its acquisition of Abscint SA, a Belgian clinical-stage radiopharmaceutical company. The transaction grants Curium global development, manufacturing, and commercialization rights to ABS-011, further expanding its oncology PET radiopharmaceutical diagnostics portfolio. ABS-011 is an investigational gallium-68-labeled positron emission tomography (PET) radiopharmaceutical diagnostic tracer targeting human epidermal growth factor receptor 2 (HER2). HER2 is an important biological target in multiple cancers, including breast cancer and gastric cancer. Based on available information, ABS-011 is designed to enable whole-body quantitative imaging of HER2 expression, and following further clinical development and regulatory approval, has the potential to provide more comprehensive HER2 status information for patient characterization and clinical assessment.

2026-08-11

US Hanford Submits Permit Modification Applications to Accelerate Tank Waste Cleanup via "Vitrification + Grouting"

The U.S. Department of Energy's Hanford Field Office recently submitted two permit modification applications to the Washington State Department of Ecology, planning to accelerate the cleanup of radioactive waste in tanks at the Hanford site through a dual-track treatment strategy of "vitrification + grouting." The DOE stated that this approach is expected to reduce risks from aging tanks and save taxpayers billions of dollars. The waste primarily targeted by these applications is low-activity liquid waste processed through the Tank-Side Cesium Removal system, which removes more than 99.9% of radioactive materials from the treated waste. The DOE stated that the proposed permit changes would integrate tank-side treatment, grout solidification, and out-of-state disposal into a standardized process to continue advancing the treatment and transfer of some waste beyond the capacity of the Waste Treatment and Immobilization Plant.

2026-08-11

OSI Systems Secures Approximately $11 Million Order to Supply Eagle M60 Mobile Cargo and Vehicle Inspection Systems

OSI Systems, Inc. announced on August 10 that its Security division has received an order worth approximately $11 million to supply Rapiscan® Eagle® M60 mobile cargo and vehicle inspection systems to an international customer, along with related operator training and maintenance training support. Ajay Mehra, President and CEO of OSI Systems, stated that the customer selected the Eagle M60 to enhance its cargo and vehicle inspection capabilities. The system offers advantages in mobile deployment and imaging performance, helping security and customs authorities conduct inspections at ports, border crossings, roadside checkpoints, and other scenarios while maintaining traffic flow efficiency. According to the company, the Rapiscan® Eagle®...

2026-08-11

Texas A&M University Leads Development of Novel Wound Treatment for New World Screwworm

On August 10, 2026, the Texas A&M Engineering Experiment Station is leading the development of fast-acting, low-residue wound treatments for livestock infected with New World screwworm. The project, funded at $1.86 million, is led by Dr. Mustafa E. S. Akbulut, Associate Professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University, with the goal of providing ranchers and veterinarians with immediately deployable field treatment tools after infection occurs in animals. New World screwworm is a parasite that feeds on living tissue. According to available data, the pest is currently spreading in Central America and Mexico, with over 150,000 animal infection cases reported. Recently, cases have also emerged in Texas and New Mexico. Federal models predict that a large-scale outbreak in Texas could result in livestock losses exceeding $1.8 billion. If left untreated, these pests can cause severe harm to livestock, companion animals, and wildlife.

2026-08-11

Morehead State University Receives $50,000 Grant to Support Nuclear Medicine Technology Bachelor's Program

Morehead State University in the United States recently received a $50,000 grant to strengthen its Bachelor of Science in Nuclear Medicine Technology program, supporting the university's efforts to train medical imaging professionals for Kentucky's healthcare system. The funding was provided by the Kentucky Board of Medical Imaging and Radiation Therapy and administered by the Kentucky Council on Postsecondary Education. The project funds were awarded through a competitive bidding process, with a focus on supporting nuclear medicine technology education programs in Kentucky, aiming to increase the number of qualified professionals entering the state's healthcare industry. The newly established nuclear medicine technology undergraduate program under Morehead State University's Department of Imaging Sciences will prepare students in the field of medical imaging...

2026-08-11

ITM Receives Complete Response Letter from FDA for ¹⁷⁷Lu-edotreotide New Drug Application

Radiopharmaceutical biotechnology company ITM Isotope Technologies Munich SE (ITM) announced on August 10 that it had received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) on August 7, 2026, regarding the New Drug Application (NDA) for its investigational drug ¹⁷⁷Lu-edotreotide (ITM-11). The drug is intended for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

2026-08-11

Former U.S. President Biden's Prostate Cancer Progress: Has Received Radiation Therapy and Hormone Therapy

The health condition of former U.S. President Joe Biden has recently drawn renewed attention. In an interview video, his son Hunter Biden stated that after Biden was diagnosed with prostate cancer, the cancer cells had metastasized, spreading to the bones and other parts of the body, and described the process as extremely painful. According to relevant information, Biden, now 83 years old, disclosed in May 2025 that he had been diagnosed with an aggressive form of prostate cancer, with cancer cells confirmed to have spread to the bones at that time. In October, a Biden spokesperson announced that he was undergoing radiation therapy and hormone therapy. Radiation therapy is one of the common nuclear technology medical applications in tumor treatment, primarily using ionizing radiation on tumor tissue to...

2026-08-10